To support the hypothesis that the beneficial effects of the combination of metformin and simvastatin on pancreatic cancer development in the KC mouse model are mediated through inhibition of YAP/TAZ activity, we first examined the YAP and TAZ expression patterns in the pancreas of KC mice. The gene discussed is WWTR1; the disease is familial pancreatic carcinoma.